You can’t turn back your chronological age, but you can measurably reduce your biological age, the wear and tear your cells have actually accumulated. Several interventions, from exercise and diet to experimental drugs and cellular reprogramming, have shown the ability to slow, stall, or partially reverse markers of aging in human studies. The most accessible ones are lifestyle changes you can start today. The most dramatic ones are still years from clinical use.
What “Aging” Actually Means at the Cellular Level
Aging isn’t one process. It’s a collection of breakdowns happening simultaneously: your DNA picks up chemical tags that silence useful genes, your cells’ energy factories (mitochondria) become less efficient, damaged “zombie” cells accumulate and leak inflammatory signals, and the protective caps on your chromosomes (telomeres) shorten with each cell division. Any serious attempt to reverse aging has to target one or more of these mechanisms.
Researchers now measure biological age using epigenetic clocks, tests that read chemical patterns on your DNA and compare them to population-wide data. The most widely used versions include the Horvath clock, which works across many tissue types but tends to underestimate age in people over 60, and two newer models called PhenoAge and GrimAge. PhenoAge combines DNA data with clinical biomarkers like blood sugar, inflammation markers, and kidney function to predict healthspan. GrimAge correlates strongly with physical decline, including walking speed, grip strength, and frailty, and is sometimes called the “death clock” for its accuracy in predicting mortality. These tools give researchers (and increasingly consumers) a concrete number to track before and after interventions.
Exercise Is the Strongest Tool You Have Now
No supplement or drug matches the anti-aging effect of regular physical activity. Exercise significantly increases mitochondrial oxidative capacity, essentially making your cells better at producing energy. Research intensity matters more than the type of exercise: cycling, resistance training, and interval work all improved mitochondrial function in studies lasting as little as four weeks, with benefits continuing to build through 24 weeks. Sessions ranged from 10 to 60 minutes, performed anywhere from twice a week to daily.
The combination of strength and endurance training appears especially powerful for one specific aging marker. A systematic review and meta-analysis found that people who combined both types of exercise increased their telomere length, while control groups who didn’t exercise saw their telomeres shorten. This effect held regardless of the participants’ age or starting telomere length. Moderate-intensity endurance work, often called “zone 2” cardio (a pace where you can hold a conversation but not comfortably sing), is the foundation most longevity-focused physicians recommend, typically 150 to 180 minutes per week, supplemented by two or three strength sessions.
NAD+ Precursors: NMN and NR
NAD+ is a molecule every cell uses to generate energy and repair DNA. Its levels drop substantially with age. Supplementing with precursors like NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) can push those levels back up.
A randomized, double-blind, placebo-controlled trial in healthy middle-aged adults found that all NMN-treated groups had statistically significant increases in blood NAD+ levels by day 30 and day 60. Physical performance improved too: walking distance on a six-minute test was significantly greater in groups taking 300, 600, or 900 mg daily compared to placebo. The sweet spot appeared to be 600 mg per day, where both NAD+ levels and physical performance peaked. Perhaps most striking, the placebo group’s biological age (measured by blood markers) increased over the 60-day study period, while all NMN groups stayed flat. Self-reported health scores also improved across treated groups.
NMN is widely available as a supplement, though regulatory status varies by country. It’s generally well tolerated at doses up to 900 mg daily based on current trial data.
Clearing Out Zombie Cells With Senolytics
Senescent cells are damaged cells that stop dividing but refuse to die. They accumulate with age and pump out inflammatory molecules that damage neighboring tissue, contributing to everything from joint pain to cardiovascular disease. Senolytic drugs work by temporarily disabling the survival mechanisms these cells use to resist their own self-destruct signals.
The most studied senolytic combination in humans is dasatinib (a cancer drug) plus quercetin (a plant flavonoid). In a pilot clinical trial of people with diabetic kidney disease, participants took this combination orally for just three days. Even that brief exposure reduced markers of senescent cell burden. The approach is deliberately intermittent: because healthy cells don’t rely on those survival pathways, a short burst can clear zombie cells without harming normal tissue.
Quercetin is available over the counter, but dasatinib is a prescription medication with real side effects. This combination is not something to self-prescribe. Several larger trials are underway to determine the right dosing schedule and which age-related conditions respond best.
Rapamycin and Metformin
Rapamycin, originally an immune-suppressing drug used in organ transplants, extends lifespan in nearly every organism tested. It works by dialing down a growth-signaling pathway that, when overactive in adulthood, accelerates aging. The longevity community has coalesced around low, intermittent dosing: typically 5 to 7 mg taken once a week, or 1 mg daily. A study in healthy elderly participants found that 1 mg daily produced no notable side effects. Some physicians are already prescribing it off-label for longevity, though no large randomized trial in healthy humans has been completed.
Metformin, the inexpensive diabetes drug taken by hundreds of millions of people worldwide, is the subject of the TAME trial (Targeting Aging with Metformin), which aims to test whether it delays heart disease, cancer, and dementia in older adults. The trial, led by the American Federation for Aging Research, is still seeking funding to launch across multiple sites. If it succeeds, it would be the first FDA-recognized trial to treat aging itself as a condition rather than its individual diseases. Metformin’s proposed mechanism involves reducing inflammation, improving how cells process sugar, and activating cellular cleanup pathways.
Epigenetic Reprogramming: The Most Radical Approach
The most ambitious strategy for reversing aging involves reprogramming cells to a younger state using a set of proteins called Yamanaka factors. These four proteins (Oct3/4, Sox2, Klf4, and c-Myc) can reset the chemical tags on DNA that accumulate with age, effectively winding back a cell’s epigenetic clock.
The process works in two phases. First, c-Myc and Klf4 kick off a stochastic (random) wave within days, opening up tightly packed DNA and silencing the cell’s current identity genes. Then Oct3/4 and Sox2 take over in a more organized phase, activating the genes associated with youth and pluripotency. Oct3/4 acts as a pioneer, physically prying open closed regions of DNA so other factors can bind. The key challenge is partial reprogramming: pushing cells just far enough to rejuvenate them without erasing their identity entirely, which would turn them into stem cells and risk tumor formation.
In animal studies, short pulses of these factors have restored vision in old mice, improved muscle regeneration, and reversed age-related changes in multiple organs. Human applications are still in early-stage research, but several biotech companies are investing heavily in bringing partial reprogramming to clinical trials within the next decade.
What Didn’t Pan Out: Young Blood Transfusions
The idea of transfusing young blood to reverse aging captured public imagination after mouse experiments showed that surgically connecting the circulatory systems of old and young animals improved some markers in the older animal. A startup called Ambrosia briefly sold young plasma transfusions for $8,000 per liter before the FDA intervened in 2019, stating that plasma from young donors has “no proven clinical benefit” for aging or age-related diseases. Ambrosia shut down.
More importantly, closer examination of the animal research revealed a twist. When researchers at UC Berkeley connected old and young mice so they shared blood equally, old blood actually harmed the young mice, reducing brain cell generation, learning ability, and liver regeneration. Young blood, on the other hand, showed no significant benefits for cognition or brain cell growth in the old mice. The real insight may not be about adding youthful factors but about identifying and blocking harmful factors in old blood that suppress tissue repair. Several research groups are now pursuing that angle, looking for specific molecules to target rather than attempting wholesale blood replacement.
Putting It Together
The interventions with the strongest current evidence for measurably slowing or reversing biological aging, ranked roughly by accessibility and evidence quality:
- Combined endurance and strength exercise: 150+ minutes of moderate cardio per week plus two to three resistance sessions. Proven to increase telomere length, boost mitochondrial function, and improve every major aging biomarker.
- NMN supplementation: 600 mg daily showed the best balance of NAD+ increase and physical performance in a controlled trial, with a measurable stall in biological age progression over 60 days.
- Caloric or dietary optimization: Lifestyle interventions combining physical activity with dietary changes showed independent telomere-lengthening effects in meta-analysis.
- Rapamycin (prescription, off-label): 5 to 7 mg weekly is the most common longevity-oriented dose. Evidence is strong in animals, preliminary in humans.
- Senolytics: Promising but still experimental in humans. Intermittent dosing protocols are being refined in clinical trials.
- Epigenetic reprogramming: The most transformative potential, but currently limited to animal research and early biotech development.
You can track the impact of whatever you choose by getting a biological age test before starting and repeating it six to twelve months later. GrimAge and PhenoAge are currently the most informative options for predicting real health outcomes rather than just estimating a number.